Similar articles

• Physiologically based pharmacokinetic modeling (PBPK's) prediction potential in clinical pharmacology decision making during pregnancy.

  Eke AC, Gebreyohannes RD. Eke AC, et al. Int J Gynaecol Obstet. 2020 Sep;150(3):414-416. doi: 10.1002/ijgo.13150. Epub 2020 Apr 21. Int J Gynaecol Obstet. 2020. PMID: 32246775 Free PMC article. No abstract available.
• Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.

  Moss DM, Marzolini C, Rajoli RK, Siccardi M. Moss DM, et al. Expert Opin Drug Metab Toxicol. 2015;11(8):1203-17. doi: 10.1517/17425255.2015.1037278. Epub 2015 Apr 15. Expert Opin Drug Metab Toxicol. 2015. PMID: 25872900 Review.
• Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

  Dallmann A, Ince I, Meyer M, Willmann S, Eissing T, Hempel G. Dallmann A, et al. Clin Pharmacokinet. 2017 Nov;56(11):1303-1330. doi: 10.1007/s40262-017-0539-z. Clin Pharmacokinet. 2017. PMID: 28401479 Review.
• Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.

  Emoto C, Fukuda T, Johnson TN, Adams DM, Vinks AA. Emoto C, et al. CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):e17. doi: 10.1002/psp4.17. Epub 2015 Feb 4. CPT Pharmacometrics Syst Pharmacol. 2015. PMID: 26225230 Free PMC article.
• Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.

  Zhao P, Zhang L, Grillo JA, Liu Q, Bullock JM, Moon YJ, Song P, Brar SS, Madabushi R, Wu TC, Booth BP, Rahman NA, Reynolds KS, Gil Berglund E, Lesko LJ, Huang SM. Zhao P, et al. Clin Pharmacol Ther. 2011 Feb;89(2):259-67. doi: 10.1038/clpt.2010.298. Epub 2010 Dec 29. Clin Pharmacol Ther. 2011. PMID: 21191381